4D Pharma PLC
LSE:DDDD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
4D Pharma PLC
Other Operating Expenses
4D Pharma PLC
Other Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
4D Pharma PLC
LSE:DDDD
|
Other Operating Expenses
£36k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Other Operating Expenses
£1.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
28%
|
CAGR 10-Years
14%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Other Operating Expenses
$252m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-17%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Other Operating Expenses
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Other Operating Expenses
£5.6m
|
CAGR 3-Years
93%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
4D Pharma PLC
Glance View
4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. The firm's LBPs are biologics based on live organisms, namely single strains of bacteria. The company has developed its research to build MicroRx, which is a discovery platform that is able to select those bacteria that have a therapeutic effect in specific diseases. The company uses MicroRx to interrogate its library of bacterial isolates to identify LBPs. Its microbiome profiling platform, MicroDx, analyses the microbiome to aid the diagnosis and treatment of patients with its Live Biotherapeutics. Its MicroRx platform has generated a pipeline of development programs in therapeutic areas, including immuno-oncology, gastrointestinal (GI), respiratory, autoimmune and central nervous system (CNS) disease. The company is conducting a phase I/II clinical study of MRx-4DP0004 in patients with poorly controlled asthma.
See Also
What is 4D Pharma PLC's Other Operating Expenses?
Other Operating Expenses
36k
GBP
Based on the financial report for Dec 31, 2021, 4D Pharma PLC's Other Operating Expenses amounts to 36k GBP.
What is 4D Pharma PLC's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 1Y
-20%
Over the last year, the Other Operating Expenses growth was -20%.
